These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 5715475

  • 1. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S.
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract] [Full Text] [Related]

  • 2. [Observations on antituberculous drug resistance among pulmonary tuberculosis patients at the national sanatoria in Kyushu district. 4. The primary and the secondary antituberculous agents].
    Yamaguchi S.
    Iryo; 1968 Oct; 22(10):1120-4. PubMed ID: 5710123
    [No Abstract] [Full Text] [Related]

  • 3. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K, Hayashida M, Ishihara M, Ijichi F, Obata Y.
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H, Takahashi R, Nakai T, Torii R, Yo I.
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract] [Full Text] [Related]

  • 5. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S, Nosaki M, Iwasaki M, Hamano S, Furuya Y.
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract] [Full Text] [Related]

  • 6. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M.
    Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863
    [No Abstract] [Full Text] [Related]

  • 7. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
    Tsukamura M.
    Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456
    [No Abstract] [Full Text] [Related]

  • 8. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M, Izumi K, Kamima H, Hirose H, Saito M.
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract] [Full Text] [Related]

  • 9. [Therapy of pulmonary tuberculosis in its current aspects].
    Gartmann JC.
    Bibl Tuberc; 1965 Jan; 20():59-70. PubMed ID: 4291161
    [No Abstract] [Full Text] [Related]

  • 10. [Evolution of antibiograms of bacilli persisting under treatment in the sanatorium].
    Marion L.
    Rev Tuberc Pneumol (Paris); 1967 Jan; 31(6):785-808. PubMed ID: 4317451
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R, Verma SK, Sahai S, Kumar S, Jain A.
    Indian J Chest Dis Allied Sci; 2006 Jan; 48(3):183-6. PubMed ID: 18610675
    [Abstract] [Full Text] [Related]

  • 12. [Primary drug resistance of Mycobacterium tuberculosis to 2d line preparations].
    Fedotova ZN, Gur'ian IE, Kochetov BI.
    Probl Tuberk; 1972 Jan; 50(11):21-4. PubMed ID: 4630564
    [No Abstract] [Full Text] [Related]

  • 13. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV, Rudoĭ NM.
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract] [Full Text] [Related]

  • 14. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
    Bialik IB.
    Antibiotiki; 1971 Feb; 16(2):184-8. PubMed ID: 4326728
    [No Abstract] [Full Text] [Related]

  • 15. [Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis].
    Mamolat AS, Bialik IB, Khutorskaia VD.
    Klin Med (Mosk); 1976 Dec; 54(12):72-8. PubMed ID: 189127
    [No Abstract] [Full Text] [Related]

  • 16. Therapeutic effect of minor antituberculosis drugs on advanced pulmonary tuberculosis.
    Ando M.
    Nagoya J Med Sci; 1967 Jan; 29(3):261-70. PubMed ID: 6074943
    [No Abstract] [Full Text] [Related]

  • 17. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA, Utkin VV, Korotaev GA, Golitsina LV.
    Probl Tuberk; 1967 Jan; 45(5):29-33. PubMed ID: 5617941
    [No Abstract] [Full Text] [Related]

  • 18. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN, Barrera L.
    Medicina (B Aires); 2007 Jan; 67(3):231-7. PubMed ID: 17628909
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.